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In Brief
The regulation of brown adipose tissue
(BAT) in humans is not well understood.
Ramage et al. show that glucocorticoids
acutely increase BAT in vivo and in vitro in
humans through increasing UCP-1.
However, glucocorticoids decrease
UCP-1 in murine beige/ brown
adipocytes, identifying species-specific
differences in the regulation of BAT
function.
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The discovery of brown adipose tissue (BAT) in adult
humans presents a new therapeutic target for meta-
bolic disease; however, little is known about the
regulation of human BAT. Chronic glucocorticoid
excess causes obesity in humans, and glucocorti-
coids suppress BAT activation in rodents. We tested
whether glucocorticoids regulate BAT activity in
humans. In vivo, the glucocorticoid prednisolone
acutely increased 18fluorodeoxyglucose uptake by
BAT (measured using PET/CT) in lean healthy men
during mild cold exposure (16C–17C). In addition,
prednisolone increased supraclavicular skin temper-
ature (measured using infrared thermography) and
energy expenditure during cold, but not warm, expo-
sure in lean subjects. In vitro, glucocorticoids
increased isoprenaline-stimulated respiration and
UCP-1 in human primary brown adipocytes, but sub-
stantially decreased isoprenaline-stimulated respira-
tion and UCP-1 in primary murine brown and beige
adipocytes. The highly species-specific regulation
of BAT function by glucocorticoids may have impor-
tant implications for the translation of novel treat-
ments to activate BAT to improve metabolic health.
INTRODUCTION
The recent discovery of brown adipose tissue (BAT) in adult hu-
mans (Virtanen et al., 2009; van Marken Lichtenbelt et al., 2009;
Saito et al., 2009) has revealed the exciting possibility of acti-
vating BAT and/or ‘‘browning’’ white adipose tissue (WAT) to
enhance energy expenditure and treat obesity, diabetes, and
even dyslipidemia (Sidossis and Kajimura, 2015). Numerous fac-
tors have been identified that induce browning in rodents, such
as FGF21, BMP8b, and natriuretic peptides (Sidossis and Kaji-
mura, 2015). However, very little is known about the function
and regulation of human BAT. Findings to date suggest similar-
ities between rodent and human BAT, for example, both are
activated by cold exposure (Saito et al., 2009) and sympathetic130 Cell Metabolism 24, 130–141, July 12, 2016 ª 2016 The Author(s
This is an open access article under the CC BY license (http://creativeactivity (Cypess et al., 2015) and contribute to cold-induced ther-
mogenesis (Ouellet et al., 2012). Recent work has focused on
whether human BAT is more closely related to rodent’’classic’’
brown or inducible ‘‘beige’’ fat (Jespersen et al., 2013; Cypess
et al., 2013; Shinoda et al., 2015), with less emphasis on deter-
mining if there are substantial differences between species in
the regulation of BAT function. Analysis of hormonal regulation
of BAT in humans has been largely overlooked to date, in part
because of the difficulty in obtaining samples for in vitro studies
or quantifying in vivo function of human BAT.
Glucocorticoids are powerful regulators of energy meta-
bolism, and chronic glucocorticoid excess causes obesity,
type 2 diabetes mellitus, and dyslipidemia (Macfarlane et al.,
2008). In rodents, it has long been known that glucocorticoids
suppress UCP-1 and thermogenesis by BAT, while adrenalec-
tomy and the glucocorticoid receptor antagonist RU38486
both increase BAT thermogenesis and UCP-1 levels (Hardwick
et al., 1989; Strack et al., 1995; van den Beukel et al., 2014). In
addition, glucocorticoids suppress browning of WAT in mice
(Kong et al., 2015). While circulating glucocorticoid levels are
regulated by the hypothalamic-pituitary-adrenal (HPA) axis, tis-
sue glucocorticoid levels in important metabolic tissues such
as liver and adipose tissue are further amplified by the enzyme
11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) (Stimson
et al., 2009). In murine brown adipocytes, overexpression of
11b-HSD1 decreases BAT function, while pharmacological
11b-HSD1 inhibition or knockdown enhances BAT activation
(Liu et al., 2013), highlighting that local glucocorticoid excess in-
hibits BAT activity in rodents. We tested the hypothesis that glu-
cocorticoids suppress BAT activation in humans as in rodents
using in vivo and in vitro approaches.
RESULTS
Glucocorticoids Increase Cold-Induced 18FDG Uptake
by Human BAT In Vivo
Six healthy men (subject characteristics in Table 1) were recruited
toa randomizeddouble-blind,placebo-controlledcrossoverstudy
(Figure 1A) to determine the effect of glucocorticoids onBATactiv-
ity. The synthetic glucocorticoid prednisolone (10 mg every 12 hr)
or placebo was administered for three doses prior to each study
visit, and positron emission tomography/computed tomography
(PET/CT) was used to measure 18fluorodeoxyglucose (18FDG)). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Table 1. Anthropometric and Biochemical Measurements in In Vivo Studies
PET/CT Study Thermal Imaging Study
Prednisolone Placebo Prednisolone Placebo
No. of participants (male/female) 6/0 5/4
Age (years) 22.1 ± 1.2 22.1 ± 1.2 22.7 ± 1.3 22.7 ± 1.3
Weight (kg) 68.7 ± 3.1 68.6 ± 3.1 65.3 ± 2.9 65.3 ± 2.8
BMI (kg/m2) 22.0 ± 0.9 22.0 ± 0.9 21.8 ± 0.6 21.8 ± 0.6
Fat mass (kg) 8.6 ± 0.9 8.4 ± 0.9 12.5 ± 1.2 12.4 ± 1.1
Systolic BP (mmHg) 128 ± 5 123 ± 5 116 ± 3 114 ± 2
Diastolic BP (mmHg) 70 ± 2 69 ± 1 66 ± 2 66 ± 3
Warm environmental temperature (C) 23.8 ± 0.2 23.5 ± 0.1 23.7 ± 0.3 24.0 ± 0.3
Cold environmental temperature (C) 17.5 ± 0.2### 17.2 ± 0.4### 16.5 ± 0.2### 16.2 ± 0.1###
Fasting Biochemistry
Glucose (mmol/L) 6.0 ± 0.3* 5.3 ± 0.3 5.0 ± 0.1* 4.4 ± 0.1
Insulin (pmol/L) 66 ± 11* 40 ± 7 56 ± 7** 28 ± 5
Total cholesterol (mmol/L) 3.8 ± 0.2 3.8 ± 0.2 4.1 ± 0.2 4.1 ± 0.2
Triglycerides (mmol/L) 0.6 ± 0.0 0.7 ± 0.1 0.8 ± 0.1 0.8 ± 0.1
NEFAs (warm room) (mmol/L) 558 ± 82* 362 ± 50 351 ± 53 244 ± 53
NEFAs (cold room) (mmol/L) 515 ± 66 391 ± 34 453 ± 54* 277 ± 71
ACTH (warm room) (ng/L) ND** 47 ± 6 ND** 49 ± 8
ACTH (cold room) (ng/L) ND** 22 ± 6## ND** 26 ± 3#
Noradrenaline (warm room) (ng/L) 305 ± 74 304 ± 82 492 ± 66 612 ± 86
Noradrenaline (cold room) (ng/L) 451 ± 120 575 ± 141 564 ± 102 611 ± 123
Data are mean ± SEM. ND, not detected. *p < 0.05, **p < 0.01 versus placebo. #p < 0.05, ##p < 0.01, ###p < 0.001 versus measurements in warm room.uptake by BAT during 2 hr of mild cold exposure (16C–17C) (van
Marken Lichtenbelt et al., 2009). Study visits took place between
March and September in Edinburgh. Average local environmental
temperatures over that period are detailed in Table S1, available
online. No subject had any symptoms or signs of shivering during
cold exposure. Prednisolone increased fasting plasma glucose,
insulin, and non-esterified fatty acids (NEFAs) and decreased
adrenocorticotrophic hormone (ACTH) and cortisol concentra-
tions compared with placebo, but did not alter noradrenaline
concentrations (Table 1). All six subjects had detectable 18FDG
uptake by BAT. Prednisolone increased cold-induced 18FDG
uptake byBAT (median total standardized uptake value 254 [inter-
quartile range, IQR 159, 556] versus 164 [98, 209] cm3 3 g/mL,
p = 0.02) (Figures 2A and 2B). In addition, prednisolone
tended to increase the volume of active BAT (71 ± 25 versus
50 ± 25 cm3, p = 0.07).
During the placebo phase, plasma cortisol concentrations fell
following normal diurnal variation while subjects were in a warm
environment, but did not fall further during cold exposure (Fig-
ure 2C). Despite increasing glucose uptake by BAT, predniso-
lone substantially decreased whole-body 6,6-[2H]2-glucose
(D2-glucose) uptake during both warm and cold conditions,
while whole-body D2-glucose uptakewas unchanged by cooling
on either placebo or prednisolone phases (Figure 2D).
Glucocorticoids Increase Energy Expenditure and
Supraclavicular Temperature during Cold Exposure
The PET study showed, surprisingly, that glucocorticoids in-
creased cold-induced 18FDG uptake by BAT, suggesting thatglucocorticoids may increase BAT thermogenesis in humans,
unlike in rodents. To test the effect of prednisolone on cold-
induced thermogenesis (using indirect calorimetry) and heat
production by BAT (using thermal imaging; Lee et al., 2011),
we performed a similar placebo-controlled, randomized cross-
over study (Figure 1B) using the same dosing structure. Subject
characteristics are detailed in Table 1. Study visits took place be-
tween January and May in the same research facility. Average
local environmental temperatures over that period are detailed
in Table S1. No subject had any symptoms or signs of shivering
during cold exposure. As in the PET study, prednisolone
increased fasting plasma glucose and insulin and suppressed
ACTH (Table 1) and cortisol (10 ± 3 versus 417 ± 22 nmol/L) con-
centrations. Prednisolone did not alter resting energy expendi-
ture in a warm environment, but increased energy expenditure
during cold exposure (Figure 3D). Prednisolone substantially
increased cold-induced thermogenesis compared with placebo
(286 ± 68 versus 125 ± 37 kcal/24 hr, p = 0.01).
Prednisolone did not alter skin temperature in the supraclavic-
ular region (BAT) or anterior chest (control) regions in warm
conditions (Figures 3B and 3E). In addition, supraclavicular
skin temperature did not significantly change following hand
immersion in 15C water for 10 min during either prednisolone
or placebo phases (+0.0C ± 0.1C and +0.1C ± 0.1C, respec-
tively). However, during cold exposure prednisolone increased
supraclavicular skin temperature compared with placebo (Fig-
ures 3A–3C) but did not alter anterior chest (Figures 3E and 3F)
or peripheral (hand) skin temperature (26.1C ± 0.7C versus
25.5C ± 0.7C).Cell Metabolism 24, 130–141, July 12, 2016 131
Figure 1. In Vivo Study Visit Protocols
Prednisolone regulation of human BAT activity was measured in vivo in two separate studies using (A) PET/CT and (B) thermal imaging. In both studies, par-
ticipants spent 2 hr in a warm room, then 2 hr in a cold room to activate BAT. In the PET/CT study, 1 hr into cold exposure, subjects were injected with 75 MBq of
18-fluoro-2-deoxyglucose (18FDG), and a PET/CT scan was performed 1 hr later. Blood (B) samples were taken at the intervals shown. In the thermal imaging
study, at the end of the second hour in the warm room, subjects placed both hands in water cooled to 15C (W15) as a mild stimulant to activate BAT. Thermal
imaging was performed at the intervals shown (T). Whole-body energy expenditure was assessed each hour using indirect calorimetry (IC).Distinct Regulation of Human BAT Activity by
Glucocorticoids In Vitro
BAT Biopsy and Culture from Human Deep
Supraclavicular Adipose Depots
A significant challenge to investigating BAT regulation in humans
has been the shortage of reliable sources of tissue from which
to culture brown adipocytes. To investigate the mechanism
whereby glucocorticoids enhance human BAT activation, we
collected adipose tissue samples from euthyroid patients under-
going elective thyroid or parathyroid surgery. Characteristics of
the participants are detailed in Table S2.
Initial work focused on obtaining human BAT without prior
PET/CT scanning. Paired samples were obtained from the su-
perficial WAT and adipose tissue depots posterior to the thyroid
(Figure S1), the typical location of human BAT (Cypess et al.,
2013). The deeper tissue had substantially higher transcript
levels of the typical BAT genes UCP-1 (1,000-fold), b3-adre-
noreceptor (b3-AR), PGC-1a, and deiodinase type 2 (DIO2)
(Figure 4A). Furthermore, although both depots consisted pre-
dominantly of white adipocytes, only tissue from the deeper
depot also contained clusters of cells with the typical appear-
ance of brown adipocytes, and immunohistochemistry
confirmed only these cells contained UCP-1 (Figures 4B and132 Cell Metabolism 24, 130–141, July 12, 20164C), proving that BAT could be successfully obtained from hu-
mans without the need for prior PET/CT scanning. mRNA levels
of the glucocorticoid receptor-a (GRa), mineralocorticoid recep-
tor (MR), cortisol-regenerating enzyme 11b-hydroxysteroid
dehydrogenase type 1 (11b-HSD1), and cortisol-inactivating
enzyme 11b-HSD2 were similarly expressed in BAT and WAT,
indicating that human BAT is likely to be a glucocorticoid-
responsive tissue (Figure 4A). To determine whether obesity
was associated with dysregulated glucocorticoid signaling in
BAT, correlations between body mass index (BMI) and GRa,
MR, 11b-HSD1, and 11b-HSD2 mRNA levels were tested in an
expanded dataset (n = 21). 11b-HSD2 mRNA levels positively
correlated with BMI in BAT (r2 = 0.31, p < 0.05), but not WAT
(r2 = 0.00), while no other significant associations were found.
In a separate patient cohort, we cultured the stromal vascular
fraction from the superficial and deeper supraclavicular adipose
tissue. Differentiated pre-adipocytes from the deeper depot
(hereafter termed brown adipocytes) retained high expression
of the typical BAT genes UCP-1, b3-AR, PRDM16, and DIO2
comparedwith differentiated pre-adipocytes from the superficial
depot (termed white adipocytes) (Figure 4D). Furthermore,
immunocytochemistry revealed that only the cultured brown ad-
ipocytes contained UCP-1 (Figure 4E). The brown adipocytes
Figure 2. Glucocorticoids Increase Cold-Induced 18FDG Uptake by BAT
(A) Paired PET/CT scans from a subject demonstrating increased 18FDG uptake in the supraclavicular BAT (arrows) during the prednisolone phase (left panel).
(B) Paired total 18FDG uptake by BAT for all six subjects; prednisolone increased uptake by BAT compared with placebo. Data were analyzed using theWilcoxon
signed-rank test.
(C)Plasmacortisol concentrations, shownasmean±SEM (n=6), fell followingnormal diurnal variation in thewarm room (p<0.05 using repeated-measuresANOVA)
but did not continue to fall during cooling (t + 120 onward) during the placebo phase (blue line), and were appropriately suppressed by prednisolone (red line).
(D) Prednisolone (red columns) decreased whole-body D2-glucose uptake compared with placebo (blue columns); whole-body D2-glucose uptake was not
altered by cold exposure. Data were analyzed using the paired t test. *p < 0.05, prednisolone versus placebo.had substantially higher expression of 11b-HSD1 and lower
expression of 11b-HSD2, while GRa and MR transcript levels
were similar between cell types (Figure 4D).
Recent conflicting reports suggest human BAT is more akin
either to rodent ‘‘beige’’ or to interscapular ‘‘classic’’ BAT (Shi-
noda et al., 2015; Cypess et al., 2013; Jespersen et al., 2013).
We measured transcripts of recently published classic brown
and beige genes, and determined that human brown adipocytes
have high expression of the beige genes TMEM26 and Tbx1, but
also high expression of the typical classic brown genes ZIC1 and
Ebf3 (Figure S2). In addition, mRNA levels of the recently
described brown and beige adipocyte marker Ebf2 (Wang
et al., 2014) were higher in the brown than white adipocytes
(0.89 ± 0.17 versus 0.62 ± 0.13 a.u., p < 0.04). This confirms pre-
vious work suggesting the molecular signature partially overlaps
(Cypess et al., 2013; Jespersen et al., 2013), although this may
vary between different depots of human BAT.
Glucocorticoid Effects on Cultured Human White and
Brown Adipocytes
To determine whether glucocorticoids enhance oxygen con-
sumption by brown adipocytes in vitro, human brown and whiteadipocytes were cultured for 24 hr in 0, 100, or 1,000 nM cortisol.
Oxygen consumption was measured on a Seahorse XFe24
analyzer. Cortisol at 100 nM increased basal and isoprenaline-
stimulated respiration by brown adipocytes compared with
0 and 1000 nM cortisol (Figure 5A). Cortisol did not alter either
basal or stimulated respiration in the white adipocytes (Fig-
ure S3A). Glucocorticoids did not alter the extracellular acidifica-
tion rate in either brown or white adipocytes (data not shown).
These results, in addition to confirming the in vivo findings, re-
vealed that glucocorticoids enhance brown adipocyte activity
directly.
To determine whether glucocorticoids enhance BAT activity
by regulating UCP-1, human primary brown adipocytes were
cultured for 24 hr in 0, 100, or 1,000 nM cortisol, as above. As
before, UCP-1 levels were substantially increased in the brown
adipocytes compared with the white adipocytes (>25-fold;
data not shown). The 100 nM cortisol concentration stimulated
UCP-1mRNA levels comparedwith both 0 and 1,000 nM cortisol
(Figure 5C). The effect of glucocorticoids on other mechanisms
that could contribute to BAT activation was also examined. In
parallel with the increased respiration and UCP-1 mRNA levels,Cell Metabolism 24, 130–141, July 12, 2016 133
Figure 3. Glucocorticoids Increase Supraclavicular Skin Temperature and Cold-Induced Thermogenesis
(A) Paired thermal images obtained from a subject on prednisolone (top panel) and placebo (lower panel) phases during cold exposure, showing increased skin
temperature in the supraclavicular regions of interest (black ovals) on the prednisolone phase.
(B) Prednisolone (red columns) increased supraclavicular skin temperature compared with placebo (blue columns) during cold exposure only; shown as mean ±
SEM (n = 9). Data are analyzed by paired t tests.
(C) The reduction in mean supraclavicular skin temperature in male (solid lines) and female (dotted lines) subjects, expressed as the absolute difference between
warm and cold environment, induced by cold exposure, was attenuated by prednisolone treatment.
(D) Prednisolone increased energy expenditure during cold, but not warm, exposure.
(E and F) Prednisolone did not alter (E) chest temperature during warm or cold exposure and did not affect (F) the reduction in mean chest temperature induced by
cold compared to warm exposure. *p < 0.05 versus placebo.100 nM cortisol increased GLUT-4 mRNA levels in brown adipo-
cytes (Figure 5C) but did not alter b3-AR, C/EBPb, PPARa,
CPT-1b, GLUT-1, or ZFP516 (the recently described upstream
regulator of UCP-1; Dempersmier et al., 2015). High-dose
cortisol (1,000 nM) increased PGC-1a mRNA levels in both
brown and white adipocytes. In white adipocytes, cortisol did
not alter mRNA levels of the other above genes (Figure S3B).
Glucocorticoids did not alter mRNA levels of the mitochondrial
markers cytochrome c and F1-ATPase or markers of adipocyte
differentiation in brown adipocytes, indicating that glucocorti-
coids were not simply enhancing mitochondrial number and ac-
tivity (Figures S3C and S3D). In addition, markers of adipocyte
differentiation were similar between white and brown adipocytes
(PPARg 0.80 ± 0.14 [WAT] versus 0.96 ± 0.11 [BAT] a.u., FABP4
1.14 ± 0.32 [WAT] versus 0.87 ± 0.13 [BAT] a.u.).
To determine whether glucocorticoids increase UCP-1 via the
glucocorticoid receptor (GR), human primary brown adipocytes
were initially incubated with the GR antagonist RU38486. How-
ever, RU38486 substantially increased UCP-1 mRNA levels in134 Cell Metabolism 24, 130–141, July 12, 2016glucocorticoid-free medium (1.6 ± 0.8 versus 0.4 ± 0.2 a.u.,
p < 0.05), as shown previously in murine brown adipocytes (Ro-
drı´guez and Palou, 2004), meaning RU38486 could not be used
for this purpose. Therefore, human primary brown adipocytes
were incubated for 24 hr with 0, 100, or 1,000 nM cortisol or
equivalent doses of dexamethasone (a selective GR agonist
27-fold more potent than cortisol) in the presence or absence
of the mineralocorticoid receptor antagonist eplerenone. Both
100 nM cortisol and 3.75 nM dexamethasone increased UCP-1
mRNA levels by 40% (Figure 5E), which was not reversed by
eplerenone. These results confirmed that high physiological,
but not supraphysiological, glucocorticoid concentrations in-
crease UCP-1 and determined that this effect ismost likelymedi-
ated through GR.
Contrasting Effects of Glucocorticoids in Human and
Murine Brown and Beige Adipocytes
These findings that glucocorticoids enhance BAT activity in hu-
mans both in vivo and in vitro, most likely by increasing UCP-1,
are at odds with consistent previous reports that glucocorticoids
Figure 4. Human BAT Biopsy and Cell Culture
(A) mRNA transcripts are shown as mean ± SEM for n = 9 for whole adipose tissue collected from the superficial (WAT, yellow columns) and deeper (BAT, red
columns) neck depots.
(B) Images obtained using 403magnification show that the superficial depot only contained adipocytes with the typical appearance of white adipocytes, while
the deeper depot also contained smaller cells with multilocular lipid droplets, more rounded nuclei, and basophilic cytoplasm (arrows), which are the typical
features of brown adipocytes.
(C) Immunohistochemistry (403 magnification) showing that only the brown adipocyte-like cells contained UCP-1 in their cytoplasm (brown staining).
(D) mRNA transcripts are shown as mean ± SEM for n = 11 for differentiated pre-adipocytes cultured from the superficial (WAT) and the deeper (BAT) depots,
showing that the BAT cells maintained a similar gene expression pattern to the whole tissue.
(E) Immunohistochemistry (403 magnification) showing that only the cultured cells from the BAT depot contained UCP-1 (brown staining, black arrows) in their
cytoplasm. Data were analyzed using paired t tests. *p < 0.05, **p < 0.01, ***p < 0.001 versus WAT.suppress BAT activation in rodents. Most of these studies have
used supraphysiological concentrations of glucocorticoids for
longer duration than in the human experiments above, and
have usually examined only interscapular classic BAT, which
may not be analogous with human BAT. To compare glucocorti-
coid regulation of BAT in humans and mice, we obtained the
epididymal and inguinal WAT and interscapular BAT from the
129 mouse strain (which readily develop browning of their
inguinal adipose depot; Wu et al., 2012) and cultured and differ-
entiated the stromal vascular fractions as in the human cells. To
induce browning of the inguinal adipocytes, following differenti-
ation half of these cells were treated with the b3-adrenoreceptor
agonist CL316,243 for 5 days (Figure S4A). Differentiated adipo-
cytes were then incubated with 0, 100, or 1,000 nM cortisol for
24 hr, as above. In marked contrast to the human brown adipo-
cytes, 100 and 1,000 nM cortisol suppressed UCP-1 mRNA
levels by 80%–85% in inguinal (Figure 5D), CL316,243-treated
inguinal, and interscapular brown adipocytes (Figure S4A–S4C).
UCP-1 levels were extremely low in the epididymal WAT andwere unchanged by cortisol. Cortisol increased PGC-1a and
GLUT-4 mRNA levels in the inguinal adipocytes (Figure 5D) as
in human brown adipocytes and decreased b3-AR, C/EBPb,
and GLUT-1 mRNA levels in the brown adipocytes (Figure S4C).
Cortisol similarly induced classic glucocorticoid-regulated
genes such as HSL, ATGL, and PER1 in both human and murine
white and brown adipocytes (Figures S3C, S3D, and S4D–S4F),
highlighting that cortisol was activating GR in both species. To
determine whether glucocorticoids also reduced respiration in
murine cells, basal and isoprenaline-stimulated oxygen con-
sumption was measured in the murine beige and brown adipo-
cytes incubated with cortisol for 24 hr as above. In contrast to
the human brown adipocytes, 100 and 1,000 nMcortisol strongly
suppressed isoprenaline-stimulated respiration in both inguinal
(Figure 5B), CL316,243-treated inguinal, and brown adipocytes
(Figures S5A and S5B).These results strongly suggested that
glucocorticoid regulation of UCP-1 was species specific; how-
ever, to determine whether lower cortisol concentrations with
shorter incubation periods could stimulate UCP-1, we incubatedCell Metabolism 24, 130–141, July 12, 2016 135
murine inguinal (unstimulated and CL316,243 treated) and
brown adipocytes with either 0, 25, 50, 100, or 1,000 nM cortisol
for both 4 and 8 hr. None of the cortisol concentrations increased
UCP-1 mRNA levels in either the brown (Figure 5F) or beige ad-
ipocytes (Figures S4G and S4H) following 4 hr incubation, and by
8 hr even the lowest cortisol concentration suppressed UCP-1 in
the brown adipocytes (Figure 5F).
Chronic Glucocorticoid Excess Suppresses In Vivo BAT
Activity in Humans
Chronic glucocorticoid excess causes obesity, so to determine
whether this acute stimulatory effect on BAT activity was main-
tained over the longer term, primary human brown adipocytes
were cultured in 0, 100, and 1,000 nM cortisol for 48 hr. The
100 nM cortisol concentration failed to increase UCP-1 following
48 hr incubation, while 1,000 nM cortisol substantially sup-
pressed UCP-1 (Figure 6A). This suggested that the acute stim-
ulatory effect on BAT activation was unlikely to be maintained
more chronically. To test this further, we performed a retrospec-
tive analysis of all patients who had undergone PET/CT scanning
in the Royal Infirmary of Edinburgh over the past 2 years. We
identified 129 patients who had been taking oral glucocorticoids
for at least 2 weeks at the time of their scan and 120 age-, sex-,
BMI-, glucose-, and disease-matched controls with no history of
any glucocorticoid use over the preceding year (Table S3). Ten of
the 249 patients (4.0%) had detectable 18FDG uptake by BAT;
these ‘‘BAT-positive’’ patients were younger (54.4 ± 6.2 versus
64.4 ± 1.0 years, p < 0.05) and had lower BMI (20.6 ± 0.7 versus
25.3 ± 0.3 kg/m2, p < 0.01) than the ‘‘BAT-negative’’ patients, in
agreement with previous data (Saito et al., 2009; Cypess et al.,
2009). Significantly fewer glucocorticoid-treated patients had
detectable BAT compared to controls (Figure 6B). The controls
had greater BAT volume and total 18FDG uptake by BAT than
glucocorticoid-treated patients (Figures 6C and 6D). In contrast
to acute glucocorticoid treatment, this shows that chronic gluco-
corticoid treatment suppresses BAT activation in humans.
DISCUSSION
This work shows that glucocorticoids acutely increase BAT ac-
tivity in humans. In vivo, the glucocorticoid prednisolone
increased 18FDG uptake by BAT, supraclavicular temperature,
and cold-induced thermogenesis during cold exposure in
healthy volunteers. Furthermore, at physiological concentrations
the endogenous glucocorticoid cortisol increased basal and
isoprenaline-stimulated respiration in human brown, but not
white, adipocytes and increased UCP-1 mRNA levels, an effect
most likely mediated through the glucocorticoid receptor. This
was in marked contrast to rodent brown and beige adipocytes,
where cortisol substantially suppressed isoprenaline-stimulated
respiration and UCP-1. Lower dose and shorter cortisol incuba-
tions also failed to induce UCP-1 in the murine adipocytes,
confirming the species-specific regulation of UCP-1 by gluco-
corticoids. These findings highlight the challenges of translating
rodent findings into humans, particularly with regard to the new
factors discovered to activate BAT or induce ‘‘browning’’ in ro-
dents, which are being proposed as possible new therapeutic
targets for human obesity (Sidossis and Kajimura, 2015). In addi-
tion, these findings highlight the importance of studying human136 Cell Metabolism 24, 130–141, July 12, 2016BAT both in vivo and in vitro and suggest, at least in relation to
regulation by glucocorticoids, that the difference between spe-
cies is greater than any differences between beige and classic
BAT. These findings also highlight the complex tissue-specific
actions of glucocorticoids, decreasing whole-body glucose up-
take (by inducing insulin resistance in tissues such as muscle)
but increasing glucose uptake by BAT. Whole-body glucose up-
take was not increased during cold exposure, signifying that the
increased glucose uptake by BAT was insufficient to impact on
whole-body glucose utilization at least during the first hour of
cold exposure.
Only one previous study has examined regulation of human
BAT by glucocorticoids (Barclay et al., 2015), demonstrating
only in vitro that the potent glucocorticoid dexamethasone sup-
pressed isoprenaline-stimulated UCP-1 levels and oxygen con-
sumption. However, the glucocorticoid concentrations used
were 30- and 300-fold higher in potency than those in the current
in vitro experiments. Since we observed that 100 nM, but not
1,000 nM, cortisol stimulated BAT activity, it is possible that
even higher glucocorticoid concentrations would have sup-
pressed BAT activity in vitro. Endogenous cortisol levels in adi-
pose tissue are approximately 25 nM (Hughes et al., 2010), so
levels of 100 nM in adipose tissue are likely to be physiologically
relevant during stress. In addition, 20mg of prednisolone per day
(which is4-foldmore potent than cortisol), as used in our in vivo
studies, would increase glucocorticoid exposure 4- to 5-fold
higher than in normal health (Kraan et al., 1998), which is equiv-
alent to cortisol production during severe stress (Boonen et al.,
2013). Therefore, high physiological glucocorticoid levels for
24 hr both in vivo and in vitro induce BAT activation.
It appears that glucocorticoid-induced thermogenesis repre-
sents a physiological response in humans. While cortisol con-
centrations during placebo administration did not rise during
cold exposure in this study or others (Ouellet et al., 2012), cortisol
did not continue to fall, as would be expected from normal
diurnal variation. Severe cold exposure sufficient to induce shiv-
ering does increase cortisol secretion (Wilson et al., 1970). We
can speculate that during severe cold exposure (or, indeed, in
combination with enhanced adrenaline secretion in the fight/
flight response), the increased cortisol secretion enhances BAT
thermogenesis to protect core body temperature. Furthermore,
recent work has determined that there is a circadian rhythm to
BAT thermogenesis in humans with elevated BAT function coin-
ciding with peak cortisol secretion early in the morning, so it is
plausible that cortisol may in part drive this circadian rhythm
(Lee et al., 2016).
The value of infrared thermography to measure BAT activity is
debated due to potential confounders such as heat production
from other tissues and changes in overlying skin blood flow;
however, our results using this technique were similar to those
obtained using PET/CT, suggesting that infrared thermography
can be used to detect cold-induced BAT activation. Importantly,
we minimized potential confounders by ensuring that subjects
wore identical clothing and that room temperatures were similar
between visits. Furthermore, it is unclear whether infrared ther-
mography data should be presented as absolute supraclavicular
skin temperatures or as the temperature gradient between
the supraclavicular skin and anterior chest (Jang et al., 2014).
However, our results were similar when calculated using the
Figure 5. Glucocorticoid Regulation of Human and Murine Brown Adipocytes In Vitro
(A and B) Data are mean ± SEM for paired (A) human brown adipocytes (n = 6) or (B) murine inguinal adipocytes (n = 7) cultured for 24 hr in either 0 (blue col-
umns), 100 (red columns), or 1,000 nM (green columns) cortisol. Cortisol (100 nM) increased basal and isoprenaline-stimulated oxygen consumption compared
with 0 and 1,000 nM in the human brown adipocytes, but 100 and 1,000 nM cortisol decreased isoprenaline-stimulated oxygen consumption in the murine
adipocytes, with basal 0 nM normalized to 100%.
(C and D) mRNA levels (with 0 nM normalized to 100%) from paired (C) human brown adipocytes (n = 8) or (D) inguinal beige adipocytes (n = 6) following 24 hr
incubation with cortisol at 0, 100, and 1,000 nM. Cortisol (100 nM) increased UCP-1 levels in human brown adipocytes but decreased UCP-1 in murine
adipocytes.
(legend continued on next page)
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Figure 6. Chronic Glucocorticoid Use Suppresses BAT Activation in Humans
(A) UCP-1mRNA levels from paired human brown adipocytes (n = 9) following 48 hr incubation with either 0 (blue columns), 100 (red columns), or 1,000 nM (green
columns) cortisol with 0 nM normalized to 100%. Data were analyzed by repeated-measures ANOVA with post hoc Bonferroni testing. Data are mean ± SEM.
(B) The prevalence of 18FDG uptake by BAT (PET/CT scanning performed 1 hr following a 400 MBq 18FDG injection at room temperature [20C–21C]) in patients
prescribed oral glucocorticoids (red column) or in matched controls (blue column). Data were analyzed by chi-square test.
(C and D) (C) The volume of active BAT (18FDG uptakewith SUVR 2.0) and (D) the total 18FDG uptake by BAT in glucocorticoid treated (red diamonds) and control
(blue diamonds) patients with detectable 18FDG uptake by BAT. BAT volume and total 18FDG uptake by BAT were reduced in glucocorticoid-treated patients.
Data were analyzed using the Mann-Whitney U test. *p < 0.05, **p < 0.01 versus control/0 nM.temperature gradient (data not shown) because the chest tem-
perature did not change between phases.
In our study, the increased levels of UCP-1 were not main-
tained following 48 hr of glucocorticoid treatment, while our
chronic PET/CT data reveal that chronic glucocorticoid excess
in fact suppresses BAT activation. While acute elevations of
cortisol represent an adaptive stress response, chronic gluco-
corticoid excess ismaladaptive and results in weight gain, insulin
resistance, and dyslipidemia (Macfarlane et al., 2008). Therefore,
suppression of BAT activation potentially contributes to these
adverse metabolic consequences of chronic glucocorticoid
treatment. It is also interesting to speculate how our findings
relate to the reduced BAT mass/activation observed in obesity(E) UCP-1 mRNA levels from paired primary human brown adipocytes (n = 7) f
concentrations (3.75 [pale red columns] and 37.5 nM [pale green columns]) of the
mineralocorticoid receptor (MR) antagonist eplerenone (10 mM). Low-dose cortiso
alter UCP-1.
(F) UCP-1 mRNA levels from paired interscapular murine brown adipocytes (n =
umns), 100, and 1,000 nM cortisol. Low- and high-dose cortisol suppressed UCP-
with post hoc Bonferroni testing. *p < 0.05, **p < 0.01 versus 0 nM; $p < 0.05, $$
138 Cell Metabolism 24, 130–141, July 12, 2016(van Marken Lichtenbelt et al., 2009). The majority of studies
find peak plasma cortisol levels to be reduced in obesity (Rask
et al., 2002; Strain et al., 1982; Phillips et al., 2000), likely due
to increased cortisol clearance by the hepatic A-ring reductases
(Andrew et al., 1998), which could result in reduced BAT cortisol
concentrations, leading to reduced thermogenesis. In addition,
we found a positive correlation between the cortisol-inactivating
enzyme 11b-HSD2 and BMI in human BAT; however, 11b-HSD2
levels in bothWAT and BAT are low, and it is unclear whether this
would substantially reduce cortisol concentrations in BAT in vivo.
An unexpected finding in this studywas the significantly elevated
11b-HSD1 and reduced 11b-HSD2 mRNA levels seen in the
brown adipocytes compared with the white adipocytes. Theseollowing 24 hr incubation with cortisol at 0, 100, and 1,000 nM or equivalent
selective glucocorticoid (GC) receptor (GR) agonist dexamethasone (Dex) ± the
l and dexamethasone increased UCP-1mRNA levels, while eplerenone did not
6) following 4 and 8 hr incubation with 0, 25 (yellow columns), 50 (orange col-
1 following 8 hr incubation. Data were analyzed by repeated-measures ANOVA
p < 0.01 versus 100 nM cortisol.
differences were not observed in thewhole tissue, so this may be
caused by increased sensitivity in the brown adipocytes to un-
known factors in the culture medium, such as macronutrients
that can induce 11b-HSD1 (Stimson et al., 2014) or glucocorti-
coids that can suppress 11b-HSD2 (Lee et al., 2008).
We examined several genes known to be important in BAT
function to determine the likely cause of the increased thermo-
genesis and the species-specific regulation by glucocorticoids.
While glucocorticoids increased PGC-1a and GLUT-4 levels in
human brown adipocytes, these were also induced in murine
inguinal adipocytes and so are not responsible for these differ-
ences in BAT function. Mitochondrial markers were not
increased, indicating that glucocorticoids likely do not improve
general mitochondrial activity. However, the clear differential
regulation of the key thermogenic protein UCP-1 between hu-
man and murine cells that importantly paralleled the differences
in isoprenaline-induced respiration likely explains the clear dif-
ferences between species, although the reason for this differen-
tial regulation is unclear. Well-known glucocorticoid-regulated
genes such as HSL, ATGL, and PER1 were induced in both mu-
rine and human adipocytes, meaning that glucocorticoids were
activating the GR signaling pathway in both species. GR binding
in BAT has not been examined to date, so it is unclear if GR binds
directly to the UCP-1 promoter region to enhance transcription.
It appears unlikely that this effect is mediated through ZFP516,
as this was unaltered in both species. In addition, prednisolone
increased NEFA concentrations, which may indirectly enhance
UCP-1 activation in BAT (Shabalina et al., 2004); however,
ATGL and HSL (key genes in lipolysis) were increased in both
species, while in vitro only 1,000 nM cortisol increased glycerol
release (a marker of lipolysis) in the medium (data not shown)
without increasing isoprenaline-stimulated oxygen consump-
tion, so it is unlikely that this mechanism drives the increased
BAT activation. Although the reason for the differential regulation
of UCP-1 between species is unclear, ACTH (which rises during
normal physiological stress) increases BAT activation in rodents
(van den Beukel et al., 2014). This may partially counteract the
suppressive effect of glucocorticoids, while acute stress en-
hances BAT thermogenesis in rats (Kataoka et al., 2014).
To conclude, we have shown that glucocorticoids acutely in-
crease BAT activity in humans at least in part by activating
UCP-1. This study highlights important species-specific differ-
ences in the regulation of BAT activation thatmay have important
implications for the translation of novel therapeutic strategies
designed to activate BAT to improve metabolic health.
EXPERIMENTAL PROCEDURES
Protocols for In Vivo Studies of BAT Activity
Glucocorticoid Regulation of Cold-Induced 18FDG Uptake by
Human BAT
Six men were recruited to a double-blind, randomized crossover study. Inclu-
sion criteria were as follows: aged 18–35 years, BMI 18.5–25 kg/m2, no
acute or chronic medical conditions, on no regular medications, alcohol intake
%21 units per week, no claustrophobia, and normal screening blood tests (full
blood count, glucose, kidney, liver, and thyroid function). Participants were
randomized to receive three doses of 10 mg prednisolone or placebo 12 hr
apart prior to each study visit (at 0800 hr and 2000 hr the day prior to each
study visit and at 0800 hr on the morning of the study visit). Volunteers were
instructed to avoid alcohol or exercise for 48 hr prior to each visit. Volunteers
attended the Clinical Research Facility at the Royal Infirmary of Edinburgh afterovernight fast in standard light clothing and wore identical clothing at each
visit. Subjects were placed in a room at 23C–24C (warm room), and mea-
surements were performed of height, weight, fat mass, and blood pressure,
and fasting blood samples were collected for glucose, insulin, ACTH, cortisol,
and NEFAs.
An infusion of 6,6-[2H]2-glucose was commenced at 0.22 mmol/kg/min for
180 min following an initial bolus of 17.6 mmol/kg (Figure 1A). Volunteers
then remained at rest in the warm room for 2 hr. Thereafter, subjects were
transferred to the Clinical Research Imaging Centre and were placed supine
in a room cooled to 17C (cold room) for 2 hr. Subjects were checked every
15min for signs or symptoms of shivering. Following 1 hr in the cold room, sub-
jects were given an intravenous injection of 75 MBq 18FDG. The PET scan
commenced 1 hr following the 18FDG injection, after a CT scan for attenuation
correction. Subjects were then allowed to return home and attended for a sec-
ond visit after at least 2 weeks washout. All studies involving human partici-
pants were reviewed and approved by the South East Scotland Research
Ethics Committee, and informed consent was obtained from all participants.
Glucocorticoid Regulation of Cold-Induced Thermogenesis and Heat
Production by Human BAT
Nine lean, healthy subjects (four female, five male) were recruited to a double-
blind, randomized crossover study. Inclusion criteria were identical to the PET
study except for additional inclusion criteria for the female participants: no cur-
rent pregnancy and alcohol intake%14 units per week. Participants were ran-
domized to receive identical dosing as in the PET study, taking three doses of
10 mg prednisolone or placebo 12 hr apart prior to each study visit, and the
study protocol was identical to the PET study except for the following differ-
ences. Subjects were placed on a bed in a warm room (23C–24C) at
t = 0min for the first 2 hr (Figure 1B). At t + 110min, subjects placed their hands
in cold water (15C) in an attempt to activate their BAT (Symonds et al., 2012).
At t + 120min, volunteers weremoved to a room cooled to 16C (cold room) for
a further 2 hr to more robustly activate their BAT. Every 20 min from t = 0 on-
ward, each subject’s peripheral temperature was measured using a tempera-
ture probe applied to the dorsum of the hand (YSI 409 series, Henleys Medical
Supplies Ltd), while thermal imaging was performed of the neck and upper
body region. Energy expenditure wasmeasured each hour using indirect calo-
rimetry. At the end of the 4 hr protocol, subjects were allowed to return home
and attended for their second visit either 2 weeks (in males) or 4 weeks (in fe-
males, to ensure menstrual cycle in the same phase at each visit) later to allow
adequate washout between phases.
PET/CT Scanning Protocol and Analysis
All subjects were placed supine in a hybrid PET/CT scanner (Biograph mCT,
Siemens Medical Systems). Subjects underwent an initial low-dose CT for
attenuation correction (non-enhanced, 120 kV) with tube current modulation
applied (20 [in healthy volunteers] or 50 [in patients] mAs quality reference) fol-
lowed by static PET imaging of the upper body using 10 (volunteers) or 3 (pa-
tients) min beds. Images were analyzed using PMOD version 3.409 (PMOD
technologies). 18FDG uptake by BAT was quantified by measuring the mean
standard uptake value (SUV) from all pixels with an SUV of greater than
2-fold background (>2.0), which corresponded to tissues with a radio density
on the CT scan with Hounsfield unit (HU) values within the expected range for
adipose tissue (from 150 to 30 HU). The total 18FDG uptake by BAT was
calculated as the mean SUV multiplied by the volume of active BAT.
Thermal Imaging
Thermal imaging was performed using a FLIR T650sc infrared camera. The
camera was placed 1 m from the subject and the subject’s upper body was
photographed at the intervals described in Figure 1B. Identically sized regions
of interest were drawn around the right and left supraclavicular regions and the
anterior chest as shown in Figure 3A using Research IR version 4 (FLIR). The
mean and maximum supraclavicular (left and right) and chest temperatures
were recorded from each image, and the mean values from all images taken
during each condition (warm, cold water, and cold exposure) are presented
in the results. The results using the mean of the mean and the mean of the
maximum were similar; as such, only the mean of the mean is presented.
Indirect Calorimetry
Energy expenditure was measured for 15 min each hour using a ventilated-
hood indirect calorimeter (GEM Nutrition). The first 5 min of data were dis-
carded and the mean value for the final 10 min recorded each hour. Energy
expenditure (EE) is presented as the mean of two values obtained duringCell Metabolism 24, 130–141, July 12, 2016 139
warm and cold exposure. Cold-induced thermogenesis was calculated by
subtracting the mean EE in the cold room from the EE in the warm room.
Glucose Kinetics
Endogenous and 6,6-[2H]2-glucose were measured using liquid chromatog-
raphy-mass spectrometry as previously described (Macfarlane et al., 2014).
The mean concentration of D2-glucose at room temperature (from t + 90 to
t + 120 min) and during the first hour of cold exposure (from t + 150 to
180 min) was used to calculate the metabolic clearance rate (MCR) of glucose
using the equation MCR = D2-glucose infusion rate/ [mean D2-glucose].
Biochemical Assays
ACTH, insulin (DRG Instruments), and noradrenaline concentrations (LDN)
were measured using commercially available ELISA kits. NEFAs were mea-
sured using a colorimetric assay (Wako Diagnostics). Cortisol was measured
by liquid chromatography-mass spectrometry as previously described (Stim-
son et al., 2009).
In Vitro Studies of BAT Activity
Detailed in the Supplemental Information.
Statistical Analysis
Data are presented asmean ±SEM. Comparisons between two related groups
were examined using the paired t test for normally distributed data, and using
the Wilcoxon signed-rank test for data not normally distributed. Comparisons
involving three or more groups were analyzed using repeated-measures
ANOVA with post hoc testing using Bonferroni correction. Associations were
tested using Pearson’s correlation coefficient with Bonferroni correction.
Data were tested for normal distribution using the one-sample Kolmogorov-
Smirnov test. p < 0.05 was considered significant. Data were analyzed using
SPSS version 19.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2016.06.011.
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